Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Related Articles by Review for PubMed (Select 20039805)

1.

Cardiac risk: not so simple.

Aberg JA, Ribaudo H.

J Infect Dis. 2010 Feb 1;201(3):315-7. doi: 10.1086/649898. No abstract available.

2.

Fenofibrate in the treatment of dyslipidemia associated with HIV infection.

Samineni D, Fichtenbaum CJ.

Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):995-1004. doi: 10.1517/17425255.2010.504715. Review.

PMID:
20604734
3.

Highly active antiretroviral therapy and coronary heart disease: the need for perspective.

Egger M, Junghans C, Friis-Møller N, Lundgren JD.

AIDS. 2001;15 Suppl 5:S193-201. Review. No abstract available.

PMID:
11816168
4.
5.

Cardiac biomarkers in persons with HIV infection: a review of the literature.

Chandler C, Dorsen C.

J Assoc Nurses AIDS Care. 2014 Jan-Feb;25(1):83-91. doi: 10.1016/j.jana.2012.11.007. Epub 2013 Mar 9. Review. No abstract available.

PMID:
23478050
6.

Does antiretroviral therapy increase or decrease the risk of cardiovascular disease?

Fichtenbaum CJ.

Curr HIV/AIDS Rep. 2010 May;7(2):92-8. doi: 10.1007/s11904-010-0045-5. Review.

PMID:
20425563
7.

Fat redistribution and bone abnormalities in HIV-infected patients.

Tebas P.

J Int Assoc Physicians AIDS Care (Chic). 2003 Apr-Jun;2(2):59-65. Review. No abstract available.

PMID:
12961759
8.

Metabolic complications of antiretroviral therapy.

Sweet DE.

Top HIV Med. 2005 Jun-Jul;13(2):70-4. Review.

9.

Clinical management considerations for dyslipidemia in HIV-infected individuals.

Kirchner JT.

Postgrad Med. 2012 Jan;124(1):31-40. doi: 10.3810/pgm.2012.01.2515. Review.

PMID:
22314112
10.

Coronary heart disease in people infected with HIV.

Malvestutto CD, Aberg JA.

Cleve Clin J Med. 2010 Aug;77(8):547-56. doi: 10.3949/ccjm.77a.09119. Review.

PMID:
20682517
11.

HIV infection, highly active antiretroviral therapy and the cardiovascular system.

Barbaro G.

Cardiovasc Res. 2003 Oct 15;60(1):87-95. Review.

12.

[Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].

Neumann T, Kondratieva J, Eggebrecht H, Wieneke H, Esser S, Bartel T, Erbel R.

Herz. 2005 Sep;30(6):504-9. Review. German.

PMID:
16170681
13.

Management of antiretroviral treatment-related complications.

Hoffman RM, Currier JS.

Infect Dis Clin North Am. 2007 Mar;21(1):103-32, ix. Review.

PMID:
17502232
14.

[HIV, AIDS and the cardiovascular risk].

Neumann T.

Internist (Berl). 2008 Apr;49(4):429-30, 432-5. doi: 10.1007/s00108-008-2049-4. Review. German.

PMID:
18305915
15.

Coronary heart disease in HIV-infected patients.

Glesby MJ.

Curr HIV/AIDS Rep. 2005 Jun;2(2):68-73. Review.

PMID:
16091251
16.

[Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].

Bani-Sadr F.

Gastroenterol Clin Biol. 2003 May;27(5):528-33. Review. French. No abstract available.

17.

Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.

[No authors listed]

Top HIV Med. 2010 Dec;18(5):164-8. Review.

18.

AIDS and lipodystrophy: complications of HIV and HIV treatments.

Laurence J.

AIDS Patient Care STDS. 1999 Jul;13(7):389-90. Review. No abstract available.

PMID:
10870591
19.

[Lipodystrophy syndrome associated with the human immunodeficiency syndrome virus (I). General characteristics and etiopathogenesis].

Blanco Quintana F, García Benayas T, Soriano Vázquez V.

Rev Clin Esp. 2002 Jan;202(1):27-31. Review. Spanish. No abstract available.

PMID:
11940431
20.

Use of antineoplastic agents in patients with cancer who have HIV/AIDS.

Rudek MA, Flexner C, Ambinder RF.

Lancet Oncol. 2011 Sep;12(9):905-12. doi: 10.1016/S1470-2045(11)70056-0. Epub 2011 May 12. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk